次世代シーケンシング市場 – 2029年までの世界予測

Report Overview

The next-generation sequencing market is expected to reach USD 22.38 billion in 2029 from USD 13.28 billion in 2024, at a CAGR of 11.0% during the forecast period.

次世代シーケンス市場は、予測期間中のCAGR 11.0%で、2024年の132億8,000万米ドルから2029年には223億8,000万米ドルに達すると予想されています。

The increasing adoption of NGS in areas like oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is a major growth driver. Moreover, improved bioinformatics tools for data analysis and interpretation are enhancing the usability of NGS, driving its widespread adoption.

腫瘍学、感染症、リプロダクティブ・ヘルス、メタゲノミクス、個別化医療などの分野における NGS の採用の増加が、主要な成長原動力となっています。さらに、データ分析と解釈のための改良されたバイオインフォマティクス ツールにより NGS の使いやすさが向上し、NGS の普及が促進されています。

“The consumables segment accounted for the largest share by products segment in the NGS market in 2023”

The NGS products market is divided into consumables, platforms, and bioinformatics tools. The consumables holds the largest share of the market in 2023. The consumables is the segment with the largest share in products. The consumables segment dominates the product type category of the NGS market. These include reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are consumed in large volumes across diverse applications. The ongoing need for high-quality consumables ensures a steady demand, unlike instruments that represent one-time purchases. Additionally, the increasing adoption of targeted sequencing and custom panels drives the demand for specialized consumables tailored for specific research and clinical applications. The growing number of NGS users, coupled with advancements in sequencing chemistries, has further increased the reliance on consumables to optimize workflows and improve data quality.

“The academic & research institutes segment accounted for the largest share by services end-user segment in the NGS market in 2023”

The NGS services market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other end users. The academic & research institutes are the segment with the largest share in the end-user segment in 2023. The large share of academic & research institutes is due to these institutions benefit from substantial government and private funding for research projects, enabling significant investments in NGS products, including instruments and consumables. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.

“The Asia Pacific region is growing at the highest CAGR in the NGS market from 2024 to 2029.”

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the rising demand for precision medicines is supporting the growth. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of sequencing technologies in healthcare management and treatment driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45% CXOs and Director-level – 30%, and Executives – 25%,
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

• Illumina, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• QIAGEN (Netherlands)
• Agilent Technologies, Inc. (US)
• Revvity (US)
• Eurofins Scientific (Luxembourg)
• PacBio (US)
• Oxford Nanopore Technologies plc. (UK)
• Takara Bio Inc. (Japan)
• BGI Group (China)
• Merck KGaA (Germany)
• BD (US)
• 10X Genomics (US)
• New England Biolabs (US)
• Promega Corporation (US)
• Novogene Co., Ltd. (China)
• LGC Limited (UK)
• WuXi Biologics (China)
• MGI Tech Co. Ltd. (China)
• Tecan Trading AG (Switzerland)
• Twist Biosciences (US)
• Azenta US, Inc. (US)
• GenScript (US)
• SD Biosensor, Inc. (South Korea)
• Fulgent Genetics (US)
• Hamilton Company (US)
• Zymo Research Corporation (US)
• NeoGenomics Laboratories (US)
• Psomagen (US)

Research Coverage:

This research report categorizes the NGS market by offerings (products and services), products by type (consumables, platforms, bioinformatics tools), consumables (library preparation kits & reagents, sequencing kits & reagents, and other consumables), platforms (sequencing platforms, library preparation platforms), bioinformatics tools (data analysis software &  workbenches, data visualization tools, and other tools), platforms by technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real time sequencing, nanopore sequencing, and other sequencing technologies), products by workflow (presequencing, sequencing , and data analysis), products by end user (academic and research institutes, pharmaceutical and biotechnology companies, clinical & diagnostics laboratories, and other end users), services by type (sequencing services, presequencing services, bioinformatics and data analysis services, and services for NGS platforms), presequencing services by type (library preparation & target enrichment, sample preparation, and quality control), sequencing services by type (exome & targeted resequencing and custom panels, rna sequencing, de novo sequencing, chip sequencing, whole genome sequencing, methyl sequencing, and other sequencing services), bioinformatics & data analysis services by type (data analysis services, data visualization and interpretation, data storage and management services), services by workflow (presequencing services, sequencing services, and data analysis services), servuces by end user (academics and research institutes, pharmaceutical and biotechnology companies, hospitals and clinical laboratories, other end users), application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), diagnostic applications (cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, and other diagnostic applications), drug discovery & development application (pharmacogenomics, and other drug discovery & development applications), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the NGS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is covered in this report

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Advancements in sequencing platforms, Rising clinical applications of sequencing, Growing demand for precision medicine, Declining sequencing cost), restraints (Data analysis complexity, High initial capital investment), opportunities (Integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (Standardization issues) influencing the growth of the market.

• Product Development/Innovation: Detailed insights on newly launched products/services of the NGS market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the genomics market
• Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US).

Table of Contents

1               INTRODUCTION              56

1.1           STUDY OBJECTIVES       56

1.2           MARKET DEFINITION   56

1.3           STUDY SCOPE   56

1.3.1        MARKETS COVERED AND REGIONAL SEGMENTATION                 57

1.3.2        INCLUSIONS & EXCLUSIONS       58

1.3.3        YEARS CONSIDERED      59

1.3.4        CURRENCY CONSIDERED            59

1.4           STAKEHOLDERS               59

1.5           SUMMARY OF CHANGES               60

2               RESEARCH METHODOLOGY       61

2.1           RESEARCH DATA              61

2.1.1        SECONDARY DATA          61

2.1.2        PRIMARY DATA 62

2.2           MARKET ESTIMATION METHODOLOGY               64

2.2.1        GLOBAL MARKET ESTIMATION 64

2.2.2        TOP-DOWN APPROACH                67

2.3           MARKET GROWTH RATE PROJECTIONS                68

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 70

2.5           RESEARCH ASSUMPTIONS           71

2.6           RESEARCH LIMITATIONS             72

2.7           RISK ANALYSIS  72

3               EXECUTIVE SUMMARY  73

4               PREMIUM INSIGHTS       78

4.1           NGS MARKET OVERVIEW             78

4.2           ASIA PACIFIC: NGS MARKET, BY COUNTRY AND PRODUCT TYPE                79

4.3           NGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              80

4.4           NGS PRODUCTS MARKET SHARE, BY END USER, 2023                 80

5               MARKET OVERVIEW       81

5.1           INTRODUCTION              81

5.2           MARKET DYNAMICS       81

5.2.1        DRIVERS               82

5.2.1.1    Advancements in sequencing platforms            82

5.2.1.1.1 Revio       83

5.2.1.1.2 PromethION 2 Solo             83

5.2.1.1.3 Ion Torrent Genexus Dx     83

5.2.1.2    Rising clinical applications of sequencing        83

5.2.1.3    Growing demand for precision medicine          84

5.2.1.4    Declining costs of sequencing            84

5.2.2        RESTRAINTS      85

5.2.2.1    Data analysis complexity     85

5.2.2.2    High capital investment and expenses               85

5.2.3        OPPORTUNITIES              85

5.2.3.1    Integration of AI and ML    85

5.2.3.2    Adoption of long-read sequencing technologies              86

5.2.3.3    Emphasis on multiomics integration 86

5.2.4        CHALLENGES    87

5.2.4.1    Standardization issues         87

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       87

5.4           REGULATORY LANDSCAPE         88

5.4.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             88

5.4.2        REGULATORY FRAMEWORK       90

5.5           VALUE CHAIN ANALYSIS               92

5.6           TECHNOLOGY ANALYSIS             94

5.6.1        KEY TECHNOLOGIES     95

5.6.1.1    Sequencing by synthesis      95

5.6.1.2    Single-molecule real-time sequencing               95

5.6.1.3    Nanopore sequencing          95

5.6.1.4    Ion semiconductor sequencing           96

5.6.2        COMPLEMENTARY TECHNOLOGIES       96

5.6.2.1    Automated sample preparation systems           96

5.6.2.2    Bioinformatics and data analysis platforms      97

5.6.2.3    CRISPR-based targeted sequencing 97

5.6.2.4    Multiplex PCR      98

5.6.3        ADJACENT TECHNOLOGIES       98

5.6.3.1    Single-cell sequencing technology     98

5.6.3.2    Multi-omics integration       98

5.6.3.3    Spatial genomics and transcriptomics               99

5.6.3.4    Gene editing technologies  99

5.7           PRICING ANALYSIS          99

5.7.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 100

5.7.1.1    Average selling price trend of instruments, by key player,

2018–2023              100

5.7.1.2    Average selling price trend of consumables, by key player,

2022–2024              101

5.7.1.3    Average selling price of services, by key player, 2024     103

5.7.2        AVERAGE SELLING PRICE, BY REGION   104

5.8           PATENT ANALYSIS          105

5.9           SUPPLY CHAIN ANALYSIS             107

5.10         ECOSYSTEM ANALYSIS  108

5.11         KEY CONFERENCES AND EVENTS, 2024–2025        110

5.12         PORTER’S FIVE FORCES ANALYSIS           111

5.12.1      INTENSITY OF COMPETITIVE RIVALRY 112

5.12.2      BARGAINING POWER OF SUPPLIERS       112

5.12.3      BARGAINING POWER OF BUYERS             112

5.12.4      THREAT OF SUBSTITUTES          112

5.12.5      THREAT OF NEW ENTRANTS      112

5.13         KEY STAKEHOLDERS AND BUYING CRITERIA     113

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           113

5.13.2      KEY BUYING CRITERIA, BY END USER    114

5.14         INVESTMENT AND FUNDING SCENARIO               115

5.15         CASE STUDY ANALYSIS 116

5.15.1      CASE STUDY 1: IDENTIFYING TANDEM REPEAT LINKED TO ALS USING SMRT SEQUENCING         116

5.15.2      CASE STUDY 2: LONG-READ WHOLE-GENOME SEQUENCING AT CHILDREN’S MERCY KANSAS CITY       117

5.15.3      CASE STUDY 3: SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES                 117

5.16         TRADE ANALYSIS             118

5.16.1      IMPORT DATA  118

5.16.2      EXPORT DATA  119

5.17         IMPACT OF AI ON NEXT-GENERATION SEQUENCING MARKET               120

6               NEXT-GENERATION SEQUENCING MARKET, BY OFFERING           122

6.1           INTRODUCTION              123

6.2           PRODUCTS         123

6.2.1        WIDE DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET                 123

6.3           SERVICES             127

6.3.1        SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET               127

7             NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE               131

7.1           INTRODUCTION              132

7.2           CONSUMABLES 132

7.2.1        LIBRARY PREPARATION & AND REAGENTS          136

7.2.1.1    Strong demand and growing applications to ensure market growth    136

7.2.2        SEQUENCING KITS & REAGENTS               140

7.2.2.1    Technological advancements to support market growth                 140

7.2.3        OTHER CONSUMABLES 144

7.3           PLATFORMS       147

7.3.1        SEQUENCING PLATFORMS          150

7.3.1.1    Illumina 153

7.3.1.1.1 NovaSeq 155

7.3.1.1.1.1              Flexibility and automated data processing to reduce time and labor cost               155

7.3.1.1.2 NextSeq 156

7.3.1.1.2.1              Introduction of advanced systems to affect demand for NextSeq 156

7.3.1.1.3 MiSeq     157

7.3.1.1.3.1              Small size and rapid operations to drive adoption in clinical labs            157

7.3.1.1.4 MiniSeq 158

7.3.1.1.4.1              Cross-application flexibility and small footprint to propel demand      158

7.3.1.1.5 iSeq 100 159

7.3.1.1.5.1              High accuracy and lower costs to support market growth                 159

7.3.1.2    Thermo Fisher Scientific     159

7.3.1.3    PacBio    160

7.3.1.4    Oxford Nanopore Technologies         161

7.3.1.5    Other sequencing platforms                162

7.3.2        LIBRARY PREPARATION PLATFORMS     162

7.3.2.1    Rising demand for sequencing in clinical applications to drive market    162

7.4           BIOINFORMATICS TOOLS            166

7.4.1        DATA ANALYSIS SOFTWARE & WORKBENCHES 170

7.4.1.1    Demand for genome analysis in clinical diagnostics to support market growth       170

7.4.2        DATA VISUALIZATION TOOLS   173

7.4.2.1    Rising demand for sequencing-based research to support market growth    173

7.4.3        OTHER BIOINFORMATICS TOOLS            177

8               NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY        180

8.1           INTRODUCTION              181

8.2           SEQUENCING BY SYNTHESIS      182

8.2.1        HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION    182

8.3           ION SEMICONDUCTOR SEQUENCING    186

8.3.1        SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH     186

8.4           SMRT SEQUENCING       190

8.4.1        RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET 190

8.5           NANOPORE SEQUENCING           193

8.5.1        DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND             193

8.6           OTHER SEQUENCING TECHNOLOGIES 197

9             NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW 201

9.1           INTRODUCTION              202

9.2           SEQUENCING    202

9.2.1        DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET             202

9.3           PRESEQUENCING            206

9.3.1        DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET GROWTH          206

9.4           DATA ANALYSIS                210

9.4.1        DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE MARKET                210

10           NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER     214

10.1         INTRODUCTION              215

10.2         ACADEMIC & RESEARCH INSTITUTES    215

10.2.1      RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH  215

10.3         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 219

10.3.1      RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET            219

10.4         CLINICAL & DIAGNOSTIC LABORATORIES           222

10.4.1      INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH               222

10.5         OTHER END USERS         226

11            NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE               230

11.1         INTRODUCTION              231

11.2         SEQUENCING SERVICES                231

11.2.1      EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS                 235

11.2.1.1  Development of technologically advanced NGS products and services to propel growth    235

11.2.2      RNA SEQUENCING          239

11.2.2.1  Technological advancements to support market growth                 239

11.2.3      DE NOVO SEQUENCING               242

11.2.3.1  Rising awareness of De Novo sequencing to drive market                 242

11.2.4      CHIP SEQUENCING         246

11.2.4.1  Increased demand for ChIP sequencing to propel growth                 246

11.2.5      WHOLE-GENOME SEQUENCING               250

11.2.5.1  Reduced cost of WGS to support market growth             250

11.2.6      METHYL SEQUENCING 253

11.2.6.1  Increased demand for methyl sequencing in cancer research to support market growth        253

11.2.7      OTHER SEQUENCING SERVICES                257

11.3         PRESEQUENCING SERVICES        260

11.3.1      LIBRARY PREPARATION & TARGET ENRICHMENT                 264

11.3.1.1  Development of advanced library preparation solutions to drive market    264

11.3.2      SAMPLE PREPARATION 268

11.3.2.1  Development of automated sample preparation solutions to boost growth    268

11.3.3      QUALITY CONTROL       271

11.3.3.1  Importance of quality control in NGS workflow to boost growth                 271

11.4         BIOINFORMATICS & DATA ANALYSIS SERVICES 274

11.4.1      DATA ANALYSIS                277

11.4.1.1  Increasing demand for genome analysis for clinical diagnosis to drive market          277

11.4.2      DATA VISUALIZATION & INTERPRETATION        281

11.4.2.1  Rising demand for sequencing-based research to support market growth    281

11.4.3      DATA STORAGE & MANAGEMENT           284

11.4.3.1  Demand for effective data management to propel market growth                 284

11.5         NGS PLATFORM SERVICES           288

11.5.1      NEED FOR COMPLIANCE AND MINIMIZING PLATFORM DOWNTIME TO DRIVE ADOPTION          288

12            NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW 291

12.1         INTRODUCTION              292

12.2         SEQUENCING    292

12.2.1      RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH          292

12.3         PRESEQUENCING SERVICES        296

12.3.1      CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH      296

12.4         DATA ANALYSIS SERVICES           299

12.4.1      RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET               299

13            NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER     303

13.1         INTRODUCTION              304

13.2         ACADEMIC & RESEARCH INSTITUTES    304

13.2.1      RISING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH             304

13.3         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 308

13.3.1      RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH        308

13.4         HOSPITALS & CLINICAL LABORATORIES               311

13.4.1      INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH               311

13.5         OTHER END USERS         315

14            NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION   319

14.1         INTRODUCTION              320

14.2         DIAGNOSTICS   320

14.2.1      CANCER DIAGNOSTICS 324

14.2.1.1  Rising demand for targeted therapies to drive market   324

14.2.2      INFECTIOUS DISEASE DIAGNOSTICS      328

14.2.2.1  Rising demand for comprehensive genomic data in clinical diagnostics to propel adoption            328

14.2.3      REPRODUCTIVE HEALTH DIAGNOSTICS              332

14.2.3.1  Focus on genetic disease diagnostics to drive growth     332

14.2.4      OTHER DIAGNOSTIC APPLICATIONS     335

14.3         DRUG DISCOVERY & DEVELOPMENT     339

14.3.1      PHARMACOGENOMICS 343

14.3.1.1  Rising use of NGS for understanding genomic variants in humans to drive growth      343

14.3.2      OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS 346

14.4         AGRICULTURE & ANIMAL RESEARCH     350

14.4.1      EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS           350

14.5         OTHER APPLICATIONS 353

15            NEXT-GENERATION SEQUENCING MARKET, BY REGION                 357

15.1         INTRODUCTION              358

15.2         NORTH AMERICA             358

15.2.1      NORTH AMERICA: MACROECONOMIC OUTLOOK                 359

15.2.2      US           367

15.2.2.1  US expected to dominate market in North America       367

15.2.3      CANADA               374

15.2.3.1  Increasing government initiatives in sequencing research to boost market growth       374

15.3         EUROPE               381

15.3.1      EUROPE: MACROECONOMIC OUTLOOK               381

15.3.2      GERMANY           389

15.3.2.1  Germany to dominate European NGS market 389

15.3.3      UK          396

15.3.3.1  Strategic initiatives and funding for genomics research to support market growth       396

15.3.4      FRANCE                403

15.3.4.1  Increasing government investment in genomics research to drive growth    403

15.3.5      ITALY    410

15.3.5.1  Favorable funding scenario to drive adoption of advanced sequencing technology         410

15.3.6      SPAIN    417

15.3.6.1  Growing focus on advancements in personalized medicine to support market growth        417

15.3.7      NETHERLANDS 424

15.3.7.1  Well-established research infrastructure to sustain demand for NGS        424

15.3.8      REST OF EUROPE             431

15.4         ASIA PACIFIC     438

15.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK     438

15.4.2      CHINA  447

15.4.2.1  China to dominate Asia Pacific market during forecast period                 447

15.4.3      JAPAN   454

15.4.3.1  Rising number of collaborations in NGS to drive market                 454

15.4.4      INDIA    461

15.4.4.1  Government and private initiatives for genomics projects to propel market        461

15.4.5      AUSTRALIA         468

15.4.5.1  Increased genetic research in Australia to support market growth                 468

15.4.6      SOUTH KOREA  475

15.4.6.1  Demand for advanced sequencing technologies to support market growth in South Korea            475

15.4.7      REST OF ASIA PACIFIC   482

15.5         LATIN AMERICA                490

15.5.1      LATIN AMERICA: MACROECONOMIC OUTLOOK                 490

15.5.2      BRAZIL 498

15.5.2.1  Increased government investments in genomics advancements to drive market          498

15.5.3      MEXICO                505

15.5.3.1  Rising demand for chronic disease treatment to support market growth in Mexico 505

15.5.4      REST OF LATIN AMERICA             512

15.6         MIDDLE EAST   520

15.6.1      MIDDLE EAST: MACROECONOMIC OUTLOOK   520

15.6.2      GCC COUNTRIES              528

15.6.2.1  Saudi Arabia          535

15.6.2.1.1                Growing healthcare expenditure in Saudi Arabia to boost market growth             535

15.6.2.2  UAE        542

15.6.2.2.1                Collaborations to advance genome sequencing and market growth       542

15.6.2.3  Rest of GCC Countries        549

15.6.3      REST OF MIDDLE EAST 557

15.7         AFRICA 565

15.7.1      GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET             565

15.7.2      AFRICA: MACROECONOMIC OUTLOOK 565

16            COMPETITIVE LANDSCAPE         573

16.1         INTRODUCTION              573

16.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            573

16.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET                573

16.3         REVENUE ANALYSIS, 2019–2023  575

16.4         MARKET SHARE ANALYSIS, 2023                 575

16.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 577

16.5.1      STARS   578

16.5.2      EMERGING LEADERS     578

16.5.3      PERVASIVE PLAYERS      578

16.5.4      PARTICIPANTS 578

16.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         580

16.5.5.1  Company footprint               580

16.5.5.2  Region footprint   581

16.5.5.3  Offering footprint 582

16.5.5.4  Application footprint            583

16.5.5.5  Technology footprint           584

16.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        586

16.6.1      PROGRESSIVE COMPANIES         586

16.6.2      RESPONSIVE COMPANIES            586

16.6.3      DYNAMIC COMPANIES  586

16.6.4      STARTING BLOCKS         586

16.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 588

16.6.5.1  Detailed list of key startups/SMEs    588

16.6.5.2  Competitive benchmarking of startups/SMEs 589

16.7         VALUATION & FINANCIAL METRICS       589

16.7.1      FINANCIAL METRICS      589

16.7.2      COMPANY VALUATION 590

16.8         BRAND/PRODUCT COMPARISON             591

16.9         COMPETITIVE SCENARIO             592

16.9.1      DEALS  592

16.9.2      EXPANSIONS     592

17            COMPANY PROFILES      593

17.1         KEY PLAYERS     593

17.1.1      ILLUMINA, INC. 593

17.1.1.1  Business overview 593

17.1.1.2  Products/services offered   595

17.1.1.3  Recent developments           597

17.1.1.3.1                Product launches  597

17.1.1.3.2                Deals      599

17.1.1.3.3                Expansions             601

17.1.1.4  MnM view              602

17.1.1.4.1                Key strengths        602

17.1.1.4.2                Strategic choices   602

17.1.1.4.3                Weaknesses and competitive threats 602

17.1.2      THERMO FISHER SCIENTIFIC INC.            603

17.1.2.1  Business overview 603

17.1.2.2  Products/services offered   604

17.1.2.3  Recent developments           607

17.1.2.3.1                Product launches, approvals, and enhancements                 607

17.1.2.3.2                Deals      610

17.1.2.3.3                Expansions             611

17.1.2.4  MnM view              612

17.1.2.4.1                Key strengths        612

17.1.2.4.2                Strategic choices   612

17.1.2.4.3                Weaknesses and competitive threats 612

17.1.3      AGILENT TECHNOLOGIES, INC.                613

17.1.3.1  Business overview 613

17.1.3.2  Products/services offered   614

17.1.3.3  Recent developments           616

17.1.3.3.1                Deals      616

17.1.3.3.2                Expansions             618

17.1.3.4  MnM view              618

17.1.3.4.1                Key strengths        618

17.1.3.4.2                Strategic choices   618

17.1.3.4.3                Weaknesses and competitive threats 618

17.1.4      F. HOFFMANN-LA ROCHE LTD. 619

17.1.4.1  Business overview 619

17.1.4.2  Products/services offered   620

17.1.4.3  Recent developments           622

17.1.4.3.1                Product launches  622

17.1.4.3.2                Deals      623

17.1.5      DANAHER CORPORATION           624

17.1.5.1  Business overview 624

17.1.5.2  Products/services offered   626

17.1.5.3  Recent developments           628

17.1.5.3.1                Product launches & approvals            628

17.1.5.3.2                Deals      629

17.1.5.3.3                Expansions             630

17.1.6      QIAGEN                631

17.1.6.1  Business overview 631

17.1.6.2  Products/services offered   632

17.1.6.3  Recent developments           635

17.1.6.3.1                Deals      636

17.1.6.3.2                Expansions             637

17.1.7      REVVITY               638

17.1.7.1  Business overview 638

17.1.7.2  Products/services offered   639

17.1.7.3  Recent developments           641

17.1.7.3.1                Product launches  641

17.1.7.3.2                Deals      642

17.1.7.3.3                Expansions             642

17.1.8      EUROFINS SCIENTIFIC  643

17.1.8.1  Business overview 643

17.1.8.2  Products/services offered   644

17.1.8.3  Recent developments           644

17.1.8.3.1                Service launches   644

17.1.8.3.2                Deals      645

17.1.9      PACBIO 646

17.1.9.1  Business overview 646

17.1.9.2  Products/services offered   647

17.1.9.3  Recent developments           650

17.1.9.3.1                Product launches  650

17.1.9.3.2                Deals      651

17.1.9.3.3                Expansions             652

17.1.9.3.4                Other developments             652

17.1.10   OXFORD NANOPORE TECHNOLOGIES PLC.        653

17.1.10.1                 Business overview 653

17.1.10.2                 Products/services offered   654

17.1.10.3                 Recent developments           656

17.1.10.3.1             Product launches  656

17.1.10.3.2             Deals      656

17.1.11   TAKARA BIO INC.             659

17.1.11.1                 Business overview 659

17.1.11.2                 Products/services offered   660

17.1.11.3                 Recent developments           662

17.1.11.3.1             Product launches  662

17.1.11.3.2             Deals      662

17.1.12   BGI GROUP         663

17.1.12.1                 Business overview 663

17.1.12.2                 Products/services offered   663

17.1.12.3                 Recent developments           666

17.1.12.3.1             Product & service launches and approvals       666

17.1.12.3.2             Deals      667

17.1.12.3.3             Other developments             668

17.1.13   BD          669

17.1.13.1                 Business overview 669

17.1.13.2                 Products/services offered   670

17.1.13.3                 Recent developments           671

17.1.13.3.1             Product & service launches 671

17.1.13.3.2             Deals      671

17.1.14   10X GENOMICS 672

17.1.14.1                 Business overview 672

17.1.14.2                 Products/services offered   673

17.1.14.3                 Recent developments           675

17.1.14.3.1             Product launches  675

17.1.15   PROMEGA CORPORATION           676

17.1.15.1                 Business overview 676

17.1.15.2                 Products/services offered   676

17.1.15.3                 Recent developments           677

17.1.15.3.1             Expansions             677

17.1.16   LGC LIMITED    678

17.1.16.1                 Business overview 678

17.1.16.2                 Products/services offered   679

17.1.16.2.1             Deals      679

17.1.17   WUXI BIOLOGICS             680

17.1.17.1                 Business overview 680

17.1.17.2                 Products/services offered   681

17.1.18   TECAN TRADING AG      682

17.1.18.1                 Business overview 682

17.1.18.2                 Products/services offered   683

17.1.18.2.1             Deals      684

17.1.19   TWIST BIOSCIENCES      685

17.1.19.1                 Business overview 685

17.1.19.2                 Products/services offered   686

17.1.19.3                 Recent developments           688

17.1.19.3.1             Product launches  688

17.1.19.3.2             Deals      688

17.1.20   AZENTA US, INC.              690

17.1.20.1                 Business overview 690

17.1.20.2                 Products & services offered                 691

17.1.20.3                 Recent developments           692

17.1.20.3.1             Deals      692

17.2         OTHER PLAYERS              693

17.2.1      MGI TECH CO. LTD.        693

17.2.2      NOVOGENE CO., LTD.   695

17.2.3      NEW ENGLAND BIOLABS              696

17.2.4      GENSCRIPT        697

17.2.5      PSOMAGEN        698

17.2.6      ZYMO RESEARCH CORPORATION             699

17.2.7      HAMILTON COMPANY  700

17.2.8      NEOGENOMICS LABORATORIES               701

17.2.9      FULGENT GENETICS      702

17.2.10   SD BIOSENSOR, INC.       703

18            APPENDIX           704

18.1         DISCUSSION GUIDE        704

18.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                710

18.3         CUSTOMIZATION OPTIONS        712

18.4         RELATED REPORTS         712

18.5         AUTHOR DETAILS           713

LIST OF TABLES

TABLE 1                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              69

TABLE 2                NGS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS          82

TABLE 3                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 88

TABLE 4                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           88

TABLE 5                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 89

TABLE 6                REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 90

TABLE 7                US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION        91

TABLE 8                US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              91

TABLE 9                AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,

2022–2024 (USD)                100

TABLE 10              AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,

2022–2024 (USD)                101

TABLE 11              AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)        103

TABLE 12              AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)        104

TABLE 13              INNOVATIONS AND PATENT REGISTRATIONS, 2020–2024              106

TABLE 14              NGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM       109

TABLE 15              NGS MARKET: LIST OF KEY CONFERENCES AND EVENTS                110

TABLE 16              NGS MARKET: IMPACT OF PORTER’S FIVE FORCES                111

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)     113

TABLE 18              KEY BUYING CRITERIA, BY END USER    114

TABLE 19              IMPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY,

2019–2023 (USD THOUSAND)      118

TABLE 20              IMPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)                119

TABLE 21              EXPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY,

2019–2023 (USD THOUSAND)      119

TABLE 22              EXPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)                120

TABLE 23              NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            123

TABLE 24              NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)       124

TABLE 25              NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            124

TABLE 26              EUROPE: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     125

TABLE 27              ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     125

TABLE 28              LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            126

TABLE 29              MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          126

TABLE 30              GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            126

TABLE 31              NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127

TABLE 32              NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            128

TABLE 33              EUROPE: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            128

TABLE 34              ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     129

TABLE 35              LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            129

TABLE 36              MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          130

TABLE 37              GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            130

TABLE 38              NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 132

TABLE 39              NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)       133

TABLE 40              NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            133

TABLE 41              EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     134

TABLE 42              ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            134

TABLE 43              LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            135

TABLE 44              MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION,

2022–2029 (USD MILLION)            135

TABLE 45             GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            135

TABLE 46              NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)       136

TABLE 47              LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            137

TABLE 48              NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               138

TABLE 49              EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 138

TABLE 50              ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 139

TABLE 51              LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 139

TABLE 52              MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)                 140

TABLE 53              GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               140

TABLE 54              SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          141

TABLE 55              NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            141

TABLE 56              EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            142

TABLE 57              ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            142

TABLE 58              LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            143

TABLE 59              MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            143

TABLE 60              GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            143

TABLE 61              OTHER NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          144

TABLE 62              NORTH AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            144

TABLE 63              EUROPE: OTHER NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 64              ASIA PACIFIC: OTHER NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 65              LATIN AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            146

TABLE 66              MIDDLE EAST: OTHER NGS CONSUMABLES MARKET, BY REGION,

2022–2029 (USD MILLION)            146

TABLE 67              GCC COUNTRIES: OTHER NGS CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            146

TABLE 68              NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)       147

TABLE 69              NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            147

TABLE 70              EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     148

TABLE 71              ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            148

TABLE 72              LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            149

TABLE 73              MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)          149

TABLE 74              GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            149

TABLE 75              NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 150

TABLE 76              SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)          150

TABLE 77              NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            151

TABLE 78              EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            151

TABLE 79              ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 80              LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 81              MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION,

2022–2029 (USD MILLION)            153

TABLE 82              GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            153

TABLE 83              ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            154

TABLE 84              ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION,

2022–2029 (USD MILLION)            154

TABLE 85              ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (UNITS)        155

TABLE 86              NOVASEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)       156

TABLE 87              NEXTSEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)       157

TABLE 88              MISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)       158

TABLE 89              MINISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)       158

TABLE 90              ISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 159

TABLE 91              THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            160

TABLE 92              THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)                 160

TABLE 93              PACBIO SEQUENCING PLATFORMS MARKET, BY REGION,

2022–2029 (USD MILLION)            161

TABLE 94              OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET,

BY REGION, 2022–2029 (USD MILLION)   162

TABLE 95              LIBRARY PREPARATION PLATFORMS MARKET, BY REGION,

2022–2029 (USD MILLION)            163

TABLE 96              NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 163

TABLE 97              EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            164

TABLE 98              ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            164

TABLE 99              LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 165

TABLE 100            MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION,

2022–2029 (USD MILLION)            165

TABLE 101            GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 165

TABLE 102            NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)          166

TABLE 103            NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            167

TABLE 104            EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            167

TABLE 105            ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            168

TABLE 106            LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            168

TABLE 107            MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION,

2022–2029 (USD MILLION)            169

TABLE 108            GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            169

TABLE 109            NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)                169

TABLE 110            DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION,

2022–2029 (USD MILLION)            170

TABLE 111            NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 112            EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            171

TABLE 113            ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               172

TABLE 114            LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               172

TABLE 115            MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,

BY REGION, 2022–2029 (USD MILLION)   173

TABLE 116            GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 117            DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)          174

TABLE 118            NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            174

TABLE 119            EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            175

TABLE 120            ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            175

TABLE 121            LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            176

TABLE 122            MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION,

2022–2029 (USD MILLION)            176

TABLE 123            GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            176

TABLE 124            OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)          177

TABLE 125            NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            177

TABLE 126            EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            178

TABLE 127            ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            178

TABLE 128            LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            179

TABLE 129            MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            179

TABLE 130            GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            179

TABLE 131            NGS TECHNOLOGIES, BY COMPANY       181

TABLE 132            NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            182

TABLE 133            NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION,

2022–2029 (USD MILLION)            183

TABLE 134            NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               183

TABLE 135            EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               184

TABLE 136            ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               184

TABLE 137            LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               185

TABLE 138            MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY REGION, 2022–2029 (USD MILLION)   185

TABLE 139            GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               185

TABLE 140            NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)            187

TABLE 141            NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)       187

TABLE 142            EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 143            ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 188

TABLE 144            LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)       189

TABLE 145            MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION) 189

TABLE 146            GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)       189

TABLE 147            NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION,

2022–2029 (USD MILLION)            190

TABLE 148            NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 149            EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 150            ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)                 192

TABLE 151            LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 152            MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022–2029 (USD MILLION)                 193

TABLE 153            GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 154            NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION,

2022–2029 (USD MILLION)            194

TABLE 155            NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 156            EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            195

TABLE 157            ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               195

TABLE 158            LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               196

TABLE 159            MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING,

BY REGION, 2022–2029 (USD MILLION)   196

TABLE 160            GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)               196

TABLE 161            NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)            197

TABLE 162            NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)       198

TABLE 163            EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES,

BY COUNTRY, 2022–2029 (USD MILLION)               198

TABLE 164            ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION) 199

TABLE 165            LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)       199

TABLE 166            MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION) 200

TABLE 167            GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)       200

TABLE 168            NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            202

TABLE 169            NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION,

2022–2029 (USD MILLION)            203

TABLE 170            NORTH AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               203

TABLE 171            EUROPE: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 204

TABLE 172            ASIA PACIFIC: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 204

TABLE 173            LATIN AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 205

TABLE 174            MIDDLE EAST: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)                 205

TABLE 175            GCC COUNTRIES: NGS PRODUCTS MARKET FOR SEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               205

TABLE 176            NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION,

2022–2029 (USD MILLION)            207

TABLE 177            NORTH AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)             207

TABLE 178            EUROPE: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)            208

TABLE 179            ASIA PACIFIC: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 180            LATIN AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 181            MIDDLE EAST: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE,

BY REGION, 2022–2029 (USD MILLION)   209

TABLE 182            GCC COUNTRIES: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)             209

TABLE 183            NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION,

2022–2029 (USD MILLION)            210

TABLE 184            NORTH AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               211

TABLE 185            EUROPE: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 211

TABLE 186            ASIA PACIFIC: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)            212

TABLE 187            LATIN AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               212

TABLE 188            MIDDLE EAST: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)                 213

TABLE 189            GCC COUNTRIES: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 190            NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       215

TABLE 191            NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)                 216

TABLE 192            NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)       216

TABLE 193            EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY COUNTRY, 2022–2029 (USD MILLION)               217

TABLE 194            ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 217

TABLE 195            LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 218

TABLE 196            MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 218

TABLE 197            GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 218

TABLE 198            NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          219

TABLE 199            NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     220

TABLE 200            EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     220

TABLE 201            ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     221

TABLE 202            LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     221

TABLE 203            MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          222

TABLE 204            GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     222

TABLE 205            NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES,

BY REGION, 2022–2029 (USD MILLION)   223

TABLE 206            NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)            224

TABLE 207            EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       224

TABLE 208            ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       225

TABLE 209            LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       225

TABLE 210            MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)       226

TABLE 211            GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       226

TABLE 212            NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            227

TABLE 213            NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            227

TABLE 214            EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY,

2022–2029 (USD MILLION)            228

TABLE 215            ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 228

TABLE 216            LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 229

TABLE 217            MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 229

TABLE 218            GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 229

TABLE 219            NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 231

TABLE 220            NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION,

2022–2029 (USD MILLION)            232

TABLE 221            NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               232

TABLE 222            EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            233

TABLE 223            ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            233

TABLE 224            LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               234

TABLE 225            MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)                 234

TABLE 226            GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               234

TABLE 227            NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            235

TABLE 228            EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)            236

TABLE 229            NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            236

TABLE 230            EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 231            ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            237

TABLE 232            LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            238

TABLE 233            MIDDLE EAST: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)            238

TABLE 234            GCC COUNTRIES: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            238

TABLE 235            RNA SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          239

TABLE 236            NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            240

TABLE 237            EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            240

TABLE 238            ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            241

TABLE 239            LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            241

TABLE 240            MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            242

TABLE 241            GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            242

TABLE 242            DE NOVO SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            243

TABLE 243            NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 243

TABLE 244            EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            244

TABLE 245            ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            244

TABLE 246            LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            245

TABLE 247            MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            245

TABLE 248            GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            245

TABLE 249            CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          247

TABLE 250            NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            247

TABLE 251          EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            248

TABLE 252            ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            248

TABLE 253            LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            249

TABLE 254            MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            249

TABLE 255            GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            249

TABLE 256            WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            250

TABLE 257            NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               251

TABLE 258            EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            251

TABLE 259            ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 252

TABLE 260            LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            252

TABLE 261            MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)                 253

TABLE 262            GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               253

TABLE 263            NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)            254

TABLE 264            NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     254

TABLE 265            EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 255

TABLE 266            ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     255

TABLE 267            LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     256

TABLE 268            MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)            256

TABLE 269            GCC COUNTRIES: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     256

TABLE 270            OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          257

TABLE 271            NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            258

TABLE 272            EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            258

TABLE 273            ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            259

TABLE 274            LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            259

TABLE 275            MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            260

TABLE 276            GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            260

TABLE 277            NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION,

2022–2029 (USD MILLION)            261

TABLE 278            NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               261

TABLE 279            EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            262

TABLE 280            ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               262

TABLE 281            LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               263

TABLE 282            MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY REGION, 2022–2029 (USD MILLION)   263

TABLE 283            GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               263

TABLE 284            NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            264

TABLE 285            LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)            265

TABLE 286            NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       265

TABLE 287            EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               266

TABLE 288            ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       266

TABLE 289            LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       267

TABLE 290            MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)       267

TABLE 291            GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       267

TABLE 292            SAMPLE PREPARATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            268

TABLE 293            NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 269

TABLE 294            EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            269

TABLE 295            ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            270

TABLE 296            LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            270

TABLE 297            MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            270

TABLE 298            GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            271

TABLE 299            QUALITY CONTROL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          271

TABLE 300            NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            272

TABLE 301            EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            272

TABLE 302            ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            273

TABLE 303            LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            273

TABLE 304            MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            273

TABLE 305            GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            274

TABLE 306            NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES,

BY REGION, 2022–2029 (USD MILLION)   274

TABLE 307            NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            275

TABLE 308            EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            275

TABLE 309            ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            276

TABLE 310            LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            276

TABLE 311            MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022–2029 (USD MILLION)            276

TABLE 312            GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            277

TABLE 313            NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         277

TABLE 314          DATA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)            278

TABLE 315            NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            278

TABLE 316            EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            279

TABLE 317            ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            279

TABLE 318            LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            280

TABLE 319            MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            280

TABLE 320            GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            280

TABLE 321            DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            281

TABLE 322            NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               282

TABLE 323            EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               282

TABLE 324            ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               283

TABLE 325            LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)             283

TABLE 326            MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   284

TABLE 327            GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               284

TABLE 328            DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            285

TABLE 329            NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               285

TABLE 330            EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 286

TABLE 331            ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 286

TABLE 332            LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               287

TABLE 333            MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)            287

TABLE 334            GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               287

TABLE 335            NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION,

2022–2029 (USD MILLION)            288

TABLE 336            NORTH AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               288

TABLE 337            EUROPE: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)                 289

TABLE 338            ASIA PACIFIC: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               289

TABLE 339            LATIN AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               290

TABLE 340            MIDDLE EAST: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES,

BY REGION, 2022–2029 (USD MILLION)   290

TABLE 341            GCC COUNTRIES: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES,

BY COUNTRY, 2022–2029 (USD MILLION)               290

TABLE 342            NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)       292

TABLE 343            NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION,

2022–2029 (USD MILLION)            293

TABLE 344            NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               293

TABLE 345            EUROPE: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY,

2022–2029 (USD MILLION)            294

TABLE 346            ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 294

TABLE 347            LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 295

TABLE 348            MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)                 295

TABLE 349            GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 295

TABLE 350            NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION,

2022–2029 (USD MILLION)            296

TABLE 351            NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               297

TABLE 352            EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)            297

TABLE 353            ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               298

TABLE 354            LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)            298

TABLE 355            MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)                 299

TABLE 356            GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               299

TABLE 357            NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION,

2022–2029 (USD MILLION)            300

TABLE 358            NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               300

TABLE 359            EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)                 301

TABLE 360            ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)            301

TABLE 361            LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               302

TABLE 362            MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE,

BY REGION, 2022–2029 (USD MILLION)   302

TABLE 363            GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE,

BY COUNTRY, 2022–2029 (USD MILLION)               302

TABLE 364            NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       304

TABLE 365            NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)                 305

TABLE 366            NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 305

TABLE 367            EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY COUNTRY, 2022–2029 (USD MILLION)               306

TABLE 368            ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 306

TABLE 369            LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 307

TABLE 370            MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 307

TABLE 371            GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 307

TABLE 372            NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          308

TABLE 373            NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     309

TABLE 374            EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     309

TABLE 375            ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     310

TABLE 376            LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     310

TABLE 377            MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          311

TABLE 378            GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     311

TABLE 379            NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)            312

TABLE 380            NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       312

TABLE 381            EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES,

BY COUNTRY, 2022–2029 (USD MILLION)               313

TABLE 382            ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       313

TABLE 383            LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       314

TABLE 384            MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 314

TABLE 385            GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)       314

TABLE 386          NGS SERVICES MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            315

TABLE 387            NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 316

TABLE 388            EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY,

2022–2029 (USD MILLION)            316

TABLE 389            ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 317

TABLE 390            LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 317

TABLE 391            MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 318

TABLE 392            GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)                 318

TABLE 393            NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            320

TABLE 394          NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            321

TABLE 395            NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            321

TABLE 396            EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            322

TABLE 397            ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            322

TABLE 398            LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            323

TABLE 399            MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            323

TABLE 400            GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            323

TABLE 401          NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            324

TABLE 402            FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)         324

TABLE 403            NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)          325

TABLE 404            NORTH AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2022–2029 (USD MILLION)            326

TABLE 405            EUROPE: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2022–2029 (USD MILLION)            326

TABLE 406            ASIA PACIFIC: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2022–2029 (USD MILLION)            327

TABLE 407            LATIN AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2022–2029 (USD MILLION)            327

TABLE 408            MIDDLE EAST: NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION,

2022–2029 (USD MILLION)            328

TABLE 409            GCC COUNTRIES: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2022–2029 (USD MILLION)            328

TABLE 410            NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION,

2022–2029 (USD MILLION)            329

TABLE 411            NORTH AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               329

TABLE 412            EUROPE: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)            330

TABLE 413            ASIA PACIFIC: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               330

TABLE 414            LATIN AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               331

TABLE 415            MIDDLE EAST: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)                 331

TABLE 416            GCC COUNTRIES: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               331

TABLE 417            NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION,

2022–2029 (USD MILLION)            332

TABLE 418            NORTH AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               333

TABLE 419            EUROPE: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)            333

TABLE 420            ASIA PACIFIC: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               334

TABLE 421            LATIN AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               334

TABLE 422            MIDDLE EAST: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS,

BY REGION, 2022–2029 (USD MILLION)   335

TABLE 423            GCC COUNTRIES: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)               335

TABLE 424            NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            336

TABLE 425            NORTH AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               336

TABLE 426            EUROPE: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            337

TABLE 427            ASIA PACIFIC: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            337

TABLE 428            LATIN AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               338

TABLE 429            MIDDLE EAST: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            338

TABLE 430            GCC COUNTRIES: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               338

TABLE 431            NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   339

TABLE 432            NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            340

TABLE 433            EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 340

TABLE 434            ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            341

TABLE 435            LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            341

TABLE 436            MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            342

TABLE 437            GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            342

TABLE 438            NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            342

TABLE 439            NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022–2029 (USD MILLION)          343

TABLE 440            NORTH AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY,

2022–2029 (USD MILLION)            344

TABLE 441            EUROPE: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY,

2022–2029 (USD MILLION)            344

TABLE 442            ASIA PACIFIC: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY,

2022–2029 (USD MILLION)            345

TABLE 443            LATIN AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY,

2022–2029 (USD MILLION)            345

TABLE 444            MIDDLE EAST: NGS MARKET FOR PHARMACOGENOMICS, BY REGION,

2022–2029 (USD MILLION)            346

TABLE 445            GCC COUNTRIES: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY,

2022–2029 (USD MILLION)            346

TABLE 446            NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   347

TABLE 447            NORTH AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     347

TABLE 448            EUROPE: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            348

TABLE 449            ASIA PACIFIC: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            348

TABLE 450            LATIN AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     349

TABLE 451            MIDDLE EAST: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            349

TABLE 452            GCC COUNTRIES: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     349

TABLE 453            NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION,

2022–2029 (USD MILLION)            350

TABLE 454            NORTH AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2022–2029 (USD MILLION)               351

TABLE 455            EUROPE: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)                 351

TABLE 456            ASIA PACIFIC: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2022–2029 (USD MILLION)               352

TABLE 457            LATIN AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2022–2029 (USD MILLION)               352

TABLE 458            MIDDLE EAST: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION) 353

TABLE 459            GCC COUNTRIES: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2022–2029 (USD MILLION)               353

TABLE 460            NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          354

TABLE 461            NORTH AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            354

TABLE 462            EUROPE: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            355

TABLE 463            ASIA PACIFIC: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            355

TABLE 464            LATIN AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            356

TABLE 465            MIDDLE EAST: NGS MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            356

TABLE 466            GCC COUNTRIES: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            356

TABLE 467            NGS MARKET, BY REGION, 2022–2029 (USD MILLION)            358

TABLE 468            NORTH AMERICA: KEY MACROINDICATORS                 359

TABLE 469            NORTH AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            360

TABLE 470            NORTH AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            361

TABLE 471            NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                361

TABLE 472            NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            361

TABLE 473            NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            362

TABLE 474            NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            362

TABLE 475            NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            362

TABLE 476            NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            363

TABLE 477            NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            363

TABLE 478            NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                363

TABLE 479            NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         364

TABLE 480            NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 364

TABLE 481            NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       365

TABLE 482            NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            365

TABLE 483            NORTH AMERICA: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            365

TABLE 484            NORTH AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              366

TABLE 485            NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            366

TABLE 486            NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       366

TABLE 487            US: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            368

TABLE 488            US: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       368

TABLE 489            US: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            368

TABLE 490            US: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)       369

TABLE 491            US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)                369

TABLE 492            US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            369

TABLE 493            US: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            370

TABLE 494            US: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            370

TABLE 495            US: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 370

TABLE 496            US: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            371

TABLE 497            US: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            371

TABLE 498            US: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       372

TABLE 499            US: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            372

TABLE 500            US: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       372

TABLE 501            US: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 373

TABLE 502            US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            373

TABLE 503            US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         373

TABLE 504            CANADA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)       375

TABLE 505            CANADA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            375

TABLE 506            CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                375

TABLE 507            CANADA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            376

TABLE 508            CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            376

TABLE 509            CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            376

TABLE 510            CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 377

TABLE 511            CANADA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                377

TABLE 512            CANADA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            377

TABLE 513            CANADA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 378

TABLE 514            CANADA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            378

TABLE 515            CANADA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       379

TABLE 516            CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 379

TABLE 517          CANADA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            379

TABLE 518            CANADA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       380

TABLE 519            CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            380

TABLE 520            CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            380

TABLE 521            EUROPE: KEY MACROINDICATORS          382

TABLE 522            EUROPE: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 382

TABLE 523            EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 383

TABLE 524            EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            383

TABLE 525            EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                383

TABLE 526            EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            384

TABLE 527            EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)          384

TABLE 528            EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            384

TABLE 529            EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 385

TABLE 530            EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                385

TABLE 531            EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            385

TABLE 532            EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 386

TABLE 533            EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            386

TABLE 534            EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       387

TABLE 535            EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 387

TABLE 536            EUROPE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            387

TABLE 537            EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       388

TABLE 538            EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            388

TABLE 539            EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            388

TABLE 540            GERMANY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)       390

TABLE 541            GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            390

TABLE 542            GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                390

TABLE 543            GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            391

TABLE 544            GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            391

TABLE 545            GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            391

TABLE 546            GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 392

TABLE 547            GERMANY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                392

TABLE 548            GERMANY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            392

TABLE 549            GERMANY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 393

TABLE 550            GERMANY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            393

TABLE 551            GERMANY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       394

TABLE 552            GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 394

TABLE 553            GERMANY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                394

TABLE 554            GERMANY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            395

TABLE 555            GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            395

TABLE 556            GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       395

TABLE 557            UK: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 396

TABLE 558            UK: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       397

TABLE 559            UK: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            397

TABLE 560            UK: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)       397

TABLE 561            UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)                398

TABLE 562            UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            398

TABLE 563            UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            398

TABLE 564            UK: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            399

TABLE 565            UK: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 399

TABLE 566            UK: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            400

TABLE 567            UK: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            400

TABLE 568            UK: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       401

TABLE 569            UK: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            401

TABLE 570            UK: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       401

TABLE 571            UK: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 402

TABLE 572            UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            402

TABLE 573            UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         402

TABLE 574            FRANCE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 403

TABLE 575            FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            404

TABLE 576            FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                404

TABLE 577            FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            404

TABLE 578            FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            405

TABLE 579            FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            405

TABLE 580            FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 405

TABLE 581            FRANCE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                406

TABLE 582            FRANCE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            406

TABLE 583            FRANCE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 407

TABLE 584            FRANCE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            407

TABLE 585            FRANCE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       408

TABLE 586            FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 408

TABLE 587            FRANCE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            408

TABLE 588            FRANCE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       409

TABLE 589            FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            409

TABLE 590            FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            409

TABLE 591            ITALY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 410

TABLE 592            ITALY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       411

TABLE 593            ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            411

TABLE 594            ITALY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            411

TABLE 595            ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            412

TABLE 596            ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            412

TABLE 597            ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 412

TABLE 598            ITALY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            413

TABLE 599            ITALY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       413

TABLE 600            ITALY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            414

TABLE 601            ITALY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            414

TABLE 602            ITALY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       415

TABLE 603            ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            415

TABLE 604            ITALY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            415

TABLE 605            ITALY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       416

TABLE 606            ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            416

TABLE 607            ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         416

TABLE 608            SPAIN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 417

TABLE 609            SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       418

TABLE 610            SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            418

TABLE 611            SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            418

TABLE 612            SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            419

TABLE 613            SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            419

TABLE 614            SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 419

TABLE 615            SPAIN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            420

TABLE 616            SPAIN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       420

TABLE 617            SPAIN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            421

TABLE 618            SPAIN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            421

TABLE 619            SPAIN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       422

TABLE 620            SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            422

TABLE 621            SPAIN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            422

TABLE 622            SPAIN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       423

TABLE 623            SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            423

TABLE 624            SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         423

TABLE 625            NETHERLANDS: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            424

TABLE 626            NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                425

TABLE 627            NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)         425

TABLE 628            NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                425

TABLE 629            NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            426

TABLE 630            NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            426

TABLE 631            NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            426

TABLE 632            NETHERLANDS: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            427

TABLE 633            NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                427

TABLE 634            NETHERLANDS: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         428

TABLE 635            NETHERLANDS: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 428

TABLE 636            NETHERLANDS: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       429

TABLE 637            NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            429

TABLE 638            NETHERLANDS: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            429

TABLE 639            NETHERLANDS: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              430

TABLE 640            NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            430

TABLE 641            NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       430

TABLE 642            REST OF EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            431

TABLE 643            REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                432

TABLE 644          REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            432

TABLE 645            REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            432

TABLE 646            REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            433

TABLE 647            REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            433

TABLE 648            REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            434

TABLE 649            REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            434

TABLE 650            REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                434

TABLE 651            REST OF EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         435

TABLE 652            REST OF EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 435

TABLE 653            REST OF EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       436

TABLE 654            REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            436

TABLE 655            REST OF EUROPE: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            436

TABLE 656            REST OF EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              437

TABLE 657            REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            437

TABLE 658            REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       437

TABLE 659            ASIA PACIFIC: KEY MACROINDICATORS                 438

TABLE 660            ASIA PACIFIC: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            440

TABLE 661            ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            440

TABLE 662            ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                440

TABLE 663            ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                441

TABLE 664            ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                441

TABLE 665            ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            441

TABLE 666            ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            442

TABLE 667            ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            442

TABLE 668            ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            443

TABLE 669            ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            443

TABLE 670            ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 444

TABLE 671            ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 444

TABLE 672            ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       445

TABLE 673            ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            445

TABLE 674            ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                445

TABLE 675            ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            446

TABLE 676            ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            446

TABLE 677            ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       446

TABLE 678            CHINA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 447

TABLE 679            CHINA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            448

TABLE 680            CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            448

TABLE 681            CHINA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            448

TABLE 682            CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            449

TABLE 683            CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            449

TABLE 684            CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 449

TABLE 685            CHINA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            450

TABLE 686            CHINA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       450

TABLE 687            CHINA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            451

TABLE 688            CHINA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            451

TABLE 689            CHINA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       452

TABLE 690          CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            452

TABLE 691            CHINA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            452

TABLE 692            CHINA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       453

TABLE 693            CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            453

TABLE 694            CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         453

TABLE 695            JAPAN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 454

TABLE 696            JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            455

TABLE 697            JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            455

TABLE 698            JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            455

TABLE 699            JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)         456

TABLE 700            JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            456

TABLE 701            JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 456

TABLE 702            JAPAN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            457

TABLE 703            JAPAN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       457

TABLE 704            JAPAN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            458

TABLE 705            JAPAN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            458

TABLE 706            JAPAN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       459

TABLE 707            JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            459

TABLE 708            JAPAN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            459

TABLE 709            JAPAN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       460

TABLE 710            JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            460

TABLE 711            JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         460

TABLE 712            INDIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 462

TABLE 713            INDIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       462

TABLE 714            INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            462

TABLE 715            INDIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            463

TABLE 716            INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            463

TABLE 717            INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            463

TABLE 718            INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 464

TABLE 719            INDIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            464

TABLE 720            INDIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       464

TABLE 721            INDIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            465

TABLE 722            INDIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            465

TABLE 723            INDIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       466

TABLE 724            INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            466

TABLE 725            INDIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            466

TABLE 726            INDIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       467

TABLE 727            INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            467

TABLE 728            INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         467

TABLE 729            AUSTRALIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)       468

TABLE 730            AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            468

TABLE 731            AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                469

TABLE 732            AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                469

TABLE 733            AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            469

TABLE 734            AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            470

TABLE 735            AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            470

TABLE 736            AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                471

TABLE 737            AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            471

TABLE 738            AUSTRALIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 472

TABLE 739            AUSTRALIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 472

TABLE 740            AUSTRALIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       473

TABLE 741            AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 473

TABLE 742            AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                473

TABLE 743            AUSTRALIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            474

TABLE 744            AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            474

TABLE 745            AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       474

TABLE 746            SOUTH KOREA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            475

TABLE 747            SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                476

TABLE 748            SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            476

TABLE 749            SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                476

TABLE 750            SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            477

TABLE 751            SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            477

TABLE 752            SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            477

TABLE 753            SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            478

TABLE 754            SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                478

TABLE 755            SOUTH KOREA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         479

TABLE 756            SOUTH KOREA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 479

TABLE 757            SOUTH KOREA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       480

TABLE 758            SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)          480

TABLE 759            SOUTH KOREA: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            480

TABLE 760          SOUTH KOREA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            481

TABLE 761            SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            481

TABLE 762            SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       481

TABLE 763            REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     482

TABLE 764            REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            483

TABLE 765            REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            483

TABLE 766            REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            483

TABLE 767            REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            484

TABLE 768            REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            484

TABLE 769            REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            485

TABLE 770            REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            485

TABLE 771            REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            486

TABLE 772            REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)            486

TABLE 773            REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         487

TABLE 774            REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)            487

TABLE 775            REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            488

TABLE 776            REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            488

TABLE 777            REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            489

TABLE 778            REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            489

TABLE 779            REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       489

TABLE 780            LATIN AMERICA: KEY MACROINDICATORS                 491

TABLE 781            LATIN AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            491

TABLE 782            LATIN AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            491

TABLE 783            LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                492

TABLE 784            LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            492

TABLE 785            LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                492

TABLE 786            LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            493

TABLE 787            LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          493

TABLE 788            LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            494

TABLE 789            LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            494

TABLE 790            LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                494

TABLE 791            LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         495

TABLE 792            LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 495

TABLE 793            LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       496

TABLE 794            LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            496

TABLE 795            LATIN AMERICA: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            496

TABLE 796            LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              497

TABLE 797            LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            497

TABLE 798            LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       497

TABLE 799            BRAZIL: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 498

TABLE 800            BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            498

TABLE 801            BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            499

TABLE 802            BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            499

TABLE 803          BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            499

TABLE 804            BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            500

TABLE 805            BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 500

TABLE 806          BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            501

TABLE 807            BRAZIL: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       501

TABLE 808            BRAZIL: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 502

TABLE 809            BRAZIL: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            502

TABLE 810            BRAZIL: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       503

TABLE 811            BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 503

TABLE 812            BRAZIL: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            503

TABLE 813            BRAZIL: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       504

TABLE 814            BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            504

TABLE 815            BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         504

TABLE 816            MEXICO: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 505

TABLE 817            MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            506

TABLE 818            MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                506

TABLE 819            MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            506

TABLE 820            MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            507

TABLE 821            MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            507

TABLE 822            MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 507

TABLE 823            MEXICO: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                508

TABLE 824            MEXICO: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            508

TABLE 825            MEXICO: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 509

TABLE 826            MEXICO: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            509

TABLE 827            MEXICO: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       510

TABLE 828            MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 510

TABLE 829            MEXICO: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            510

TABLE 830            MEXICO: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       511

TABLE 831            MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            511

TABLE 832            MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            511

TABLE 833            REST OF LATIN AMERICA: NGS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            512

TABLE 834            REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            513

TABLE 835            REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            513

TABLE 836            REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            513

TABLE 837            REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            514

TABLE 838            REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            514

TABLE 839            REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            515

TABLE 840            REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            515

TABLE 841            REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            516

TABLE 842            REST OF LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION) 516

TABLE 843            REST OF LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)            517

TABLE 844            REST OF LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)         517

TABLE 845            REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            518

TABLE 846            REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            518

TABLE 847            REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            519

TABLE 848            REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            519

TABLE 849            REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            519

TABLE 850            MIDDLE EAST: KEY MACROINDICATORS                 521

TABLE 851            MIDDLE EAST: NGS MARKET, BY REGION, 2022–2029 (USD MILLION)       521

TABLE 852            MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            521

TABLE 853            MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                522

TABLE 854            MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            522

TABLE 855            MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                522

TABLE 856            MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            523

TABLE 857            MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            523

TABLE 858            MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            523

TABLE 859            MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            524

TABLE 860          MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            524

TABLE 861            MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 525

TABLE 862            MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 525

TABLE 863            MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       526

TABLE 864            MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            526

TABLE 865            MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                526

TABLE 866            MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            527

TABLE 867            MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            527

TABLE 868            MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       527

TABLE 869            GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            528

TABLE 870            GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            528

TABLE 871            GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                529

TABLE 872          GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            529

TABLE 873            GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)         529

TABLE 874            GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            530

TABLE 875            GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            530

TABLE 876            GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            531

TABLE 877            GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            531

TABLE 878            GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                531

TABLE 879            GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         532

TABLE 880            GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 532

TABLE 881            GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       533

TABLE 882            GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            533

TABLE 883            GCC COUNTRIES: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            533

TABLE 884            GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              534

TABLE 885            GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            534

TABLE 886            GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       534

TABLE 887            SAUDI ARABIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            535

TABLE 888            SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                536

TABLE 889            SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            536

TABLE 890            SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)                536

TABLE 891            SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            537

TABLE 892            SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            537

TABLE 893            SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            537

TABLE 894            SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            538

TABLE 895            SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                538

TABLE 896            SAUDI ARABIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 539

TABLE 897            SAUDI ARABIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 539

TABLE 898            SAUDI ARABIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       540

TABLE 899            SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            540

TABLE 900            SAUDI ARABIA: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            540

TABLE 901            SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            541

TABLE 902            SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            541

TABLE 903            SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       541

TABLE 904            UAE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 542

TABLE 905            UAE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       543

TABLE 906            UAE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            543

TABLE 907            UAE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)       543

TABLE 908            UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)         544

TABLE 909            UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            544

TABLE 910            UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            544

TABLE 911            UAE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)            545

TABLE 912            UAE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       545

TABLE 913            UAE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            546

TABLE 914            UAE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            546

TABLE 915            UAE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       547

TABLE 916            UAE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)            547

TABLE 917            UAE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            547

TABLE 918            UAE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 548

TABLE 919            UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            548

TABLE 920            UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         548

TABLE 921            REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            549

TABLE 922            REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            550

TABLE 923            REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            550

TABLE 924            REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            550

TABLE 925            REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)            551

TABLE 926            REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            551

TABLE 927            REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            552

TABLE 928            REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            552

TABLE 929            REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            553

TABLE 930            REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION) 553

TABLE 931            REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)            554

TABLE 932            REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)         554

TABLE 933            REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            555

TABLE 934            REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            555

TABLE 935            REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            556

TABLE 936            REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         556

TABLE 937            REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            556

TABLE 938            REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     557

TABLE 939            REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            558

TABLE 940            REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)          558

TABLE 941            REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE,

2022–2029 (USD MILLION)            558

TABLE 942            REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            559

TABLE 943            REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            559

TABLE 944            REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            560

TABLE 945            REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            560

TABLE 946            REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            561

TABLE 947            REST OF MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)            561

TABLE 948            REST OF MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES,

BY TYPE, 2022–2029 (USD MILLION)         562

TABLE 949            REST OF MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)            562

TABLE 950            REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            563

TABLE 951            REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            563

TABLE 952            REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            564

TABLE 953            REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            564

TABLE 954            REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            564

TABLE 955            MACROECONOMIC OUTLOOK FOR NGS MARKET IN AFRICA         566

TABLE 956            AFRICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 566

TABLE 957            AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            566

TABLE 958            AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            567

TABLE 959            AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)            567

TABLE 960            AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,

2022–2029 (USD MILLION)            567

TABLE 961            AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            568

TABLE 962            AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 568

TABLE 963            AFRICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                569

TABLE 964            AFRICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       569

TABLE 965            AFRICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)                 570

TABLE 966            AFRICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE,

2022–2029 (USD MILLION)            570

TABLE 967            AFRICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)       571

TABLE 968            AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 571

TABLE 969            AFRICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            571

TABLE 970            AFRICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)       572

TABLE 971            AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            572

TABLE 972            AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         572

TABLE 973            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NGS MARKET            573

TABLE 974            NGS MARKET: DEGREE OF COMPETITION                 576

TABLE 975            NGS MARKET: REGION FOOTPRINT        581

TABLE 976            NGS MARKET: OFFERING FOOTPRINT   582

TABLE 977            NGS MARKET: APPLICATION FOOTPRINT                 583

TABLE 978            NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT       584

TABLE 979            NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES              588

TABLE 980            NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES       589

TABLE 981            NGS MARKET: DEALS, JANUARY 2021– DECEMBER 2024                592

TABLE 982            NGS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024                592

TABLE 983            ILLUMINA: COMPANY OVERVIEW            593

TABLE 984            ILLUMINA: PRODUCTS/SERVICES OFFERED                 595

TABLE 985            ILLUMINA: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024     597

TABLE 986            ILLUMINA: DEALS, JANUARY 2021–DECEMBER 2024        599

TABLE 987            ILLUMINA: EXPANSIONS, JANUARY 2021–DECEMBER 2024                601

TABLE 988            THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW          603

TABLE 989            THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED               604

TABLE 990            THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–DECEMBER 2024                607

TABLE 991            THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024     610

TABLE 992            THERMO FISHER SCIENTIFIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024 611

TABLE 993            AGILENT TECHNOLOGIES: COMPANY OVERVIEW          613

TABLE 994            AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED               614

TABLE 995            AGILENT TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024        616

TABLE 996            AGILENT TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024     616

TABLE 997            AGILENT TECHNOLOGIES: EXPANSIONS, JANUARY 2021–DECEMBER 2024 618

TABLE 998            F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW          619

TABLE 999            F. HOFFMANN-LA ROCHE: PRODUCTS/SERVICES OFFERED               620

TABLE 1000         F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024        622

TABLE 1001         F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021–DECEMBER 2024     623

TABLE 1002         DANAHER CORPORATION: COMPANY OVERVIEW          624

TABLE 1003         DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED               626

TABLE 1004         DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–DECEMBER 2024 628

TABLE 1005         DANAHER CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024     629

TABLE 1006         DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024 630

TABLE 1007         QIAGEN: COMPANY OVERVIEW 631

TABLE 1008         QIAGEN: PRODUCTS/SERVICES OFFERED                 632

TABLE 1009         QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024                635

TABLE 1010         QIAGEN: DEALS, JANUARY 2021–DECEMBER 2024        636

TABLE 1011         QIAGEN: EXPANSIONS, JANUARY 2021–DECEMBER 2024                637

TABLE 1012         REVVITY: COMPANY OVERVIEW               638

TABLE 1013         REVVITY: PRODUCTS/SERVICES OFFERED                 639

TABLE 1014         REVVITY: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024                641

TABLE 1015         REVVITY: DEALS, JANUARY 2021–DECEMBER 2024        642

TABLE 1016         REVVITY: EXPANSIONS, JANUARY 2021–DECEMBER 2024                642

TABLE 1017         EUROFINS SCIENTIFIC: COMPANY OVERVIEW                 643

TABLE 1018         EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED             644

TABLE 1019         EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024 644

TABLE 1020         EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024                645

TABLE 1021         PACBIO: COMPANY OVERVIEW 646

TABLE 1022         PACBIO: PRODUCTS/SERVICES OFFERED                 647

TABLE 1023         PACBIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024                650

TABLE 1024         PACBIO: DEALS, JANUARY 2021–DECEMBER 2024                 651

TABLE 1025         PACBIO: EXPANSIONS, JANUARY 2021–DECEMBER 2024                652

TABLE 1026         PACBIO: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024     652

TABLE 1027         OXFORD NANOPORE TECHNOLOGIES: COMPANY OVERVIEW   653

TABLE 1028         OXFORD NANOPORE TECHNOLOGIES: PRODUCTS/SERVICES OFFERED               654

TABLE 1029         OXFORD NANOPORE TECHNOLOGIES: PRODUCT LAUNCHES,

JANUARY 2021–DECEMBER 2024 656

TABLE 1030         OXFORD NANOPORE TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024 656

TABLE 1031         TAKARA BIO: COMPANY OVERVIEW       659

TABLE 1032         TAKARA BIO: PRODUCTS/SERVICES OFFERED                 660

TABLE 1033         TAKARA BIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024     662

TABLE 1034         TAKARA BIO: DEALS, JANUARY 2021–DECEMBER 2024        662

TABLE 1035         BGI GROUP: COMPANY OVERVIEW         663

TABLE 1036         BGI GROUP: PRODUCTS/SERVICES OFFERED                 663

TABLE 1037         BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 666

TABLE 1038         BGI GROUP: DEALS, JANUARY 2021–DECEMBER 2024        667

TABLE 1039         BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024     668

TABLE 1040         BD: COMPANY OVERVIEW           669

TABLE 1041         BD: PRODUCTS/SERVICES OFFERED      670

TABLE 1042         BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024     671

TABLE 1043         BD: DEALS, JANUARY 2021–DECEMBER 2024                 671

TABLE 1044         10X GENOMICS: COMPANY OVERVIEW  672

TABLE 1045         10X GENOMICS: PRODUCTS/SERVICES OFFERED             673

TABLE 1046         10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 675

TABLE 1047         PROMEGA CORPORATION: COMPANY OVERVIEW          676

TABLE 1048         PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED               676

TABLE 1049         PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024 677

TABLE 1050         LGC LIMITED: COMPANY OVERVIEW     678

TABLE 1051         LGC LIMITED: PRODUCTS/SERVICES OFFERED                 679

TABLE 1052         LGC LIMITED: DEALS, JANUARY 2021–DECEMBER 2024                679

TABLE 1053         WUXI BIOLOGICS: COMPANY OVERVIEW                 680

TABLE 1054         WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED             681

TABLE 1055         TECAN TRADING AG: COMPANY OVERVIEW                 682

TABLE 1056         TECAN TRADING AG: PRODUCTS/SERVICES OFFERED             683

TABLE 1057         TECAN TRADING AG: DEALS, JANUARY 2021–DECEMBER 2024                684

TABLE 1058         TWIST BIOSCIENCE: COMPANY OVERVIEW                 685

TABLE 1059         TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED             686

TABLE 1060         TWIST BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 688

TABLE 1061         TWIST BIOSCIENCE: DEALS, JANUARY 2021–DECEMBER 2024                688

TABLE 1062         AZENTA US: COMPANY OVERVIEW          690

TABLE 1063         AZENTA US: PRODUCTS & SERVICES OFFERED                 691

TABLE 1064         AZENTA US: DEALS, JANUARY 2021–DECEMBER 2024        692

LIST OF FIGURES

FIGURE 1              RESEARCH DESIGN         61

FIGURE 2              NGS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS      63

FIGURE 3              NGS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023                 64

FIGURE 4              MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE

ANALYSIS-BASED ESTIMATION), 2023     65

FIGURE 5              REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)        65

FIGURE 6              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             66

FIGURE 7              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                67

FIGURE 8              NGS MARKET: CAGR PROJECTIONS         68

FIGURE 9              DATA TRIANGULATION METHODOLOGY                 70

FIGURE 10            NGS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)            73

FIGURE 11            NGS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)       74

FIGURE 12            NGS PLATFORMS MARKET, BY TECHNOLOGY 2024 VS. 2029 (USD MILLION)      74

FIGURE 13            NGS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 75

FIGURE 14            NGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 76

FIGURE 15            NGS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)       76

FIGURE 16            NGS MARKET: GEOGRAPHIC SNAPSHOT                 77

FIGURE 17            TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING TO

DRIVE MARKET GROWTH            78

FIGURE 18            CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN ASIA PACIFIC IN 2023  79

FIGURE 19            CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       80

FIGURE 20            ACADEMIC & RESEARCH INSTITUTES TO DOMINATE PRODUCTS MARKET DURING FORECAST PERIOD                 80

FIGURE 21            NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES     81

FIGURE 22            REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS    87

FIGURE 23            NGS MARKET: VALUE CHAIN ANALYSIS 92

FIGURE 24            VALUE CHAIN ANALYSIS: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE            93

FIGURE 25            AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)               101

FIGURE 26            AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2024 (USD)         102

FIGURE 27            AVERAGE SELLING PRICE OF SERVICES, 2024 (USD)    103

FIGURE 28            AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)        104

FIGURE 29            PATENT ANALYSIS FOR NGS MARKET, 2014–2024                 105

FIGURE 30            NGS MARKET: SUPPLY CHAIN ANALYSIS                 108

FIGURE 31            NGS MARKET: ECOSYSTEM ANALYSIS    108

FIGURE 32            NGS MARKET: PORTER’S FIVE FORCES ANALYSIS            111

FIGURE 33            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS              113

FIGURE 34            KEY BUYING CRITERIA, BY END USER    114

FIGURE 35            RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS,

2020–2024 (USD MILLION)            116

FIGURE 36            IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 121

FIGURE 37            NORTH AMERICA: NGS MARKET SNAPSHOT                 360

FIGURE 38            ASIA PACIFIC: NGS MARKET SNAPSHOT                 439

FIGURE 39            REVENUE ANALYSIS OF KEY PLAYERS IN NGS MARKET,

2019–2023 (USD MILLION)            575

FIGURE 40            NGS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)    576

FIGURE 41            NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023       579

FIGURE 42            NGS MARKET: COMPANY FOOTPRINT   580

FIGURE 43            NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                587

FIGURE 44            EV/EBITDA OF KEY VENDORS   589

FIGURE 45            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                590

FIGURE 46            NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            591

FIGURE 47            ILLUMINA: COMPANY SNAPSHOT (2023)                 594

FIGURE 48            THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023)             604

FIGURE 49            AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)             614

FIGURE 50            F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)             620

FIGURE 51            DANAHER CORPORATION: COMPANY SNAPSHOT (2023)             625

FIGURE 52            QIAGEN: COMPANY SNAPSHOT (2023)   632

FIGURE 53            REVVITY: COMPANY SNAPSHOT (2023)  639

FIGURE 54            EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)    643

FIGURE 55            PACBIO: COMPANY SNAPSHOT (2023)    647

FIGURE 56            OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2023)      654

FIGURE 57            TAKARA BIO: COMPANY SNAPSHOT (2023)                 660

FIGURE 58            BD: COMPANY SNAPSHOT (2023)              670

FIGURE 59            10X GENOMICS: COMPANY SNAPSHOT (2023)                 673

FIGURE 60            LGC LIMITED: COMPANY SNAPSHOT (2023)                 678

FIGURE 61            WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)                 681

FIGURE 62            TECAN TRADING AG: COMPANY SNAPSHOT (2023)    683

FIGURE 63            TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)    686

FIGURE 64            AZENTA US: COMPANY SNAPSHOT (2023)                 691

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
• スマートメーター市場 – 2030年までの世界予測 2025-03-07
• 産業用計測市場 – 2030年までの世界予測 2025-03-06
• 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
• グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06

MarketsandMarkets  出版レポート一覧